JP2022526018A5 - - Google Patents

Info

Publication number
JP2022526018A5
JP2022526018A5 JP2021559829A JP2021559829A JP2022526018A5 JP 2022526018 A5 JP2022526018 A5 JP 2022526018A5 JP 2021559829 A JP2021559829 A JP 2021559829A JP 2021559829 A JP2021559829 A JP 2021559829A JP 2022526018 A5 JP2022526018 A5 JP 2022526018A5
Authority
JP
Japan
Prior art keywords
aav capsid
amino acid
aav
acid sequence
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021559829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526018A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027708 external-priority patent/WO2020210655A1/en
Publication of JP2022526018A publication Critical patent/JP2022526018A/ja
Publication of JP2022526018A5 publication Critical patent/JP2022526018A5/ja
Priority to JP2025065562A priority Critical patent/JP2025106514A/ja
Withdrawn legal-status Critical Current

Links

JP2021559829A 2019-04-11 2020-04-10 脳内への特異性が増強されたウイルス組成物 Withdrawn JP2022526018A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025065562A JP2025106514A (ja) 2019-04-11 2025-04-11 脳内への特異性が増強されたウイルス組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962832826P 2019-04-11 2019-04-11
US62/832,826 2019-04-11
PCT/US2020/027708 WO2020210655A1 (en) 2019-04-11 2020-04-10 Virus compositions with enhanced specificity in the brain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025065562A Division JP2025106514A (ja) 2019-04-11 2025-04-11 脳内への特異性が増強されたウイルス組成物

Publications (2)

Publication Number Publication Date
JP2022526018A JP2022526018A (ja) 2022-05-20
JP2022526018A5 true JP2022526018A5 (cg-RX-API-DMAC7.html) 2023-03-31

Family

ID=72751358

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021559829A Withdrawn JP2022526018A (ja) 2019-04-11 2020-04-10 脳内への特異性が増強されたウイルス組成物
JP2025065562A Pending JP2025106514A (ja) 2019-04-11 2025-04-11 脳内への特異性が増強されたウイルス組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025065562A Pending JP2025106514A (ja) 2019-04-11 2025-04-11 脳内への特異性が増強されたウイルス組成物

Country Status (9)

Country Link
US (1) US12644131B2 (cg-RX-API-DMAC7.html)
EP (1) EP3953371A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022526018A (cg-RX-API-DMAC7.html)
KR (1) KR20220007056A (cg-RX-API-DMAC7.html)
CN (1) CN114127090A (cg-RX-API-DMAC7.html)
AU (1) AU2020271108A1 (cg-RX-API-DMAC7.html)
CA (1) CA3136658A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202111249YA (cg-RX-API-DMAC7.html)
WO (1) WO2020210655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021530218A (ja) 2018-07-11 2021-11-11 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. 血液脳関門を超える薬剤の送達のための方法および組成物
US11149256B2 (en) 2018-09-26 2021-10-19 California Institute Of Technology Adeno-associated virus compositions for targeted gene therapy
CN113166208B (zh) 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
EP4061947A4 (en) 2019-11-22 2024-04-24 California Institute of Technology METHODS FOR ROBUST CONTROL OF GENE EXPRESSION
CA3167290A1 (en) 2020-01-10 2021-07-15 The Brigham And Women's Hospital, Inc. Methods and compositions for delivery of immunotherapy agents across the blood-brain barrier to treat brain cancer
US12630842B2 (en) 2020-05-13 2026-05-19 Voyager Therapeutics, Inc. Redirection of tropism of AAV capsids
US20240067678A1 (en) * 2020-12-16 2024-02-29 Children's Medical Research Institute Adeno-associated virus capsids and vectors
JP2024500115A (ja) * 2020-12-18 2024-01-04 エイシー イミューン ソシエテ アノニム 抗体デリバリー
EP4322976A4 (en) * 2021-04-13 2025-06-25 Capsida, Inc. AAV COMPOSITIONS WITH HIGH EXPRESSION LEVELS IN THE BRAIN
WO2022221421A2 (en) * 2021-04-13 2022-10-20 Capsida, Inc. Aav compositions with high brain expression for treating mucopolysaccharidosis ii
US20250281643A1 (en) * 2021-04-13 2025-09-11 Capsida, Inc. Selected aav compositions having preferred brain enrichment
AU2022266615A1 (en) * 2021-04-27 2023-11-09 The General Hospital Corporation Aav capsids and uses thereof
EP4334332A4 (en) * 2021-05-04 2025-11-12 California Inst Of Techn VAA RECOMMENDANTS FOR ADMINISTRATION TO THE CENTRAL NERVOUS SYSTEM AND CEREBRAL VASCULATURE
US20240325568A1 (en) * 2021-07-20 2024-10-03 The Broad Institute, Inc. Engineered targeting compositions for endothelial cells of the central nervous system vasculature and methods of use thereof
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
EP4426716A1 (en) 2021-11-02 2024-09-11 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
WO2023091934A1 (en) * 2021-11-16 2023-05-25 California Institute Of Technology Adeno-associated virus compositions having preferred heart and skeletal muscle enrichment
EP4473001A1 (en) * 2022-02-01 2024-12-11 The Broad Institute, Inc. Adeno-associated viral vectors and uses thereof
WO2023150632A2 (en) * 2022-02-02 2023-08-10 The Broad Institute, Inc. Targeting moieties promoting transduction of central nervous system cells and tissues and methods of use
CN119095867A (zh) * 2022-03-24 2024-12-06 卡西达公司 具有优选的脑富集的所选aav组合物
EP4532515A1 (en) * 2022-06-02 2025-04-09 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
KR20240014846A (ko) * 2022-07-26 2024-02-02 숙명여자대학교산학협력단 Aav2-anks1a 재조합 바이러스를 포함하는 알츠하이머 질병 치료용 조성물
AU2023364350A1 (en) 2022-10-19 2025-06-05 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
CN116693633B (zh) * 2023-02-21 2023-12-22 广州派真生物技术有限公司 腺相关病毒突变体及其应用
JP2026509271A (ja) 2023-03-10 2026-03-17 ダイノ セラピューティクス,インコーポレーテッド カプシドポリペプチドおよびその使用方法
CN116983437B (zh) * 2023-07-26 2025-08-12 武汉大学中南医院 一种αOlig2的无损影像标记方法和产物及其用途
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
CN121219415A (zh) * 2023-10-19 2025-12-26 北京脑科学与类脑研究所 一种脑血管内皮细胞嵌合型启动子和重组表达载体及应用
WO2025155923A1 (en) * 2024-01-17 2025-07-24 The Broad Institute, Inc. Aav capsid modifications that enable improved cns-wide gene delivery through interactions with the transferrin receptor
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2025250454A1 (en) 2024-05-28 2025-12-04 University Of Rochester Adeno-associated viruses evolved to specifically target human glial progenitor cells in vivo
US20260061079A1 (en) * 2024-08-22 2026-03-05 Uniqure Biopharma B.V. BBB interacting capsids
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
CN121758572B (zh) * 2026-03-03 2026-06-09 凌意(杭州)生物科技有限公司 Aav9衣壳蛋白变体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1696036B1 (en) 1996-09-06 2010-04-21 The Trustees of The University of Pennsylvania Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
PL2900686T3 (pl) * 2012-09-28 2021-01-25 The University Of North Carolina At Chapel Hill Wektory aav ukierunkowane na oligodendrocyty
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
AU2016366549B2 (en) * 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
CA3014637A1 (en) 2016-02-16 2017-08-24 Mark A. Kay Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
MX2020001997A (es) * 2017-08-28 2020-07-20 Univ California Variantes de capside de virus adenoasociado y metodos de uso de estas.

Similar Documents

Publication Publication Date Title
Zheng et al. Lentiviral vectors and adeno‐associated virus vectors: useful tools for gene transfer in pain research
Castle et al. Controlling AAV tropism in the nervous system with natural and engineered capsids
ES2256265T3 (es) Vectores de parvovirus duplicados.
DE69429260T2 (de) Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie
JP6387350B2 (ja) 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター
JP7082050B2 (ja) 脊髄性筋萎縮症の処置において有用なアデノ-関連ウイルスベクター
JP2024540221A (ja) Aavカプシドバリアント及びその使用
TW202346599A (zh) Aav衣殼變異體及其用途
JP2024513949A5 (cg-RX-API-DMAC7.html)
EP3561062A1 (en) Selective recovery
Federici et al. Gene‐based treatment of motor neuron diseases
JP7034951B2 (ja) 操作されたウイルスベクターは炎症および免疫応答の誘導を低減する
CN108699565A (zh) 用于定向腺相关病毒(aav)的靶向肽
JP2019089787A5 (cg-RX-API-DMAC7.html)
Zhou et al. Adeno-associated virus engineering and load strategy for tropism modification, immune evasion and enhanced transgene expression
JP2017536116A5 (cg-RX-API-DMAC7.html)
TW201629225A (zh) 第九因子基因療法
CA3121528A1 (en) Anellosomes and methods of use
CN121219423A (zh) 工程化血脑屏障穿透型aav衣壳
WO2021247995A2 (en) Compositions and methods of treating neuropathic pain
CN115960921A (zh) 一组肝靶向新型腺相关病毒的获得及其应用
CN113574176A (zh) 腺相关病毒对cln6多核苷酸的递送
JP2024515626A5 (cg-RX-API-DMAC7.html)
JP2023543361A (ja) Neurod1及びdlx2ベクター
Lundstrom Application of viruses for gene therapy and vaccine development